期刊论文详细信息
Frontiers in Medicine
Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
Medicine
Sebastian Hueper1  Jan Portegys1  Matthias Froehlich1  Marc Schmalzing1  Michael Gernert1  Patrick-Pascal Strunz1  Philipp Ziebell2  Antonia Zahner2  Andrea Kübler2  Johannes Hewig2  Eva Christina Schwaneck3  Ottar Gadeholt4 
[1] Department of Internal Medicine II, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, Germany;Department of Psychology I, Institute of Psychology, University of Würzburg, Würzburg, Germany;MVZ Rheumatologie und Autoimmunmedizin, Hamburg, Germany;Rheumatologische Schwerpunktpraxis Würzburg, Würzburg, Germany;
关键词: giant cell arteritis;    PRO;    depression;    mental impairment;    SF-36;    PHQ-9;    VAS;    polymyalgia rheumatica;   
DOI  :  10.3389/fmed.2023.1146815
 received in 2023-01-17, accepted in 2023-04-25,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

ObjectivesThe spectrum of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) represents highly inflammatory rheumatic diseases. Patients mostly report severe physical impairment. Possible consequences for mental health have been scarcely studied. The aim of this study was to investigate psychological well-being in the context of GCA and PMR.MethodsCross-sectional study with N = 100 patients with GCA and/or PMR (GCA-PMR). Patient-reported outcomes (PROs) were measured using the Short Form 36 Version 2 (SF-36v2) and visual analog scale (VAS) assessment. Moreover, the Patient Health Questionnaire 9 (PHQ-9) was used in 35 of 100 patients to detect depression. To compare PROs with physician assessment, VAS was also rated from physician perspective. To assess a possible association with inflammation itself, serological parameters of inflammation (C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) were included.ResultsIn all scales of the SF-36v2 except General Health (GH) and in the physical and mental sum score (PCS, MCS), a significant impairment compared to the German reference collective was evident (MCS: d = 0.533, p < 0.001). In the PHQ-9 categorization, 14 of the 35 (40%) showed evidence of major depression disorder. VAS Patient correlated significantly with PHQ-9 and SF-36 in all categories, while VAS Physician showed only correlations to physical categories and not in the mental dimensions. Regarding inflammatory parameters, linear regression showed CRP to be a complementary significant positive predictor of mental health subscale score, independent of pain.ConclusionPRO show a relevant impairment of mental health up to symptoms of major depression disorder. The degree of depressive symptoms is also distinctly associated with the serological inflammatory marker CRP.

【 授权许可】

Unknown   
Copyright © 2023 Froehlich, Zahner, Schmalzing, Gernert, Strunz, Hueper, Portegys, Schwaneck, Gadeholt, Kübler, Hewig and Ziebell.

【 预 览 】
附件列表
Files Size Format View
RO202310101130441ZK.pdf 1302KB PDF download
  文献评价指标  
  下载次数:3次 浏览次数:0次